Agena Bioscience® in the News

Recent Press Releases

  • Agena Bioscience Bolsters MassARRAY Insights™ Reporting Network by Adding N-of-One More

    The collaboration will focus on results interpretation for cancer genomics. San Diego, CA, October 5, 2017– Agena Bioscience,...

  • Highly Sensitive Assessment Of Common Somatic Mutations In Pulmonary Non-Small Cell Carcinoma With the MassARRAY® System More

    San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting...

  • Agena Bioscience Announces Molecular Health As The First Interpretation Software Provider For MassARRAY Insights™ More

    MassARRAY Insights providers will aid in results interpretation San Diego, CA, September 19, 2017– Agena Bioscience, a...

  • Intermountain Precision Genomics Launches Antidepressant PGx Panels Developed on Agena MassARRAY® More

    NEW YORK, Sept 15, 2017 – Intermountain Precision Genomics’ RxMatch Antidepressant Panel, announced last week, is the...

  • MassARRAY® System Selected for Illinois State Cystic Fibrosis Screening of Newborns More

    San Diego, CA, August 2, 2017– Agena Bioscience has entered into a 3-year agreement with the Illinois Department of Public...

  • Agena Bioscience and Heartgenetics Announce Co-Marketing Alliance More

    HEARTDECODE® Software and Assays Designed for Use with the MassARRAY® DX System San Diego, CA, July 18, 2017– Agena...

  • Agena Bioscience and Intermountain Healthcare Announce Research Collaboration to Advance Precision Medicine More

    SAN DIEGO, CA, AND SAINT GEORGE, UTAH – Agena Bioscience and Intermountain Healthcare announced today a strategic collaboration...

  • Agena Bioscience Launches CE-IVD System For Hospitals And Diagnostic Laboratories In Europe More

    MassARRAY® System with Chip Prep Module receives CE-IVD marking for general in vitro diagnostic use in Europe SAN DIEGO,...

  • Agena Bioscience Announces Expanded Partnership With Assurex Health More

    MassARRAY® System Selected for Assurex Health’s GeneSight Test SAN DIEGO, Calif., June 20, 2017– Agena Bioscience...

  • Agena Bioscience Introduces New Lung and Colon Cancer Panels for Detection of Somatic Mutations from Liquid Biopsies and Solid Tumor Tissues More

    SAN DIEGO, Calif., March 15, 2017 — Agena Bioscience today introduced new targeted research panels for the detection of...

  • Multiplexed Analysis of ALK, ROS1, and RET Rearrangements in Lung Cancer Enabled by the MassARRAY® System More

    SAN DIEGO, Calif., February 9, 2017 – Agena Bioscience today announced a comparative study published in Scientific Reports...

  • Agena Bioscience Names Genelex as Certified Service Provider for Targeted Genetic Analysis More

    SAN DIEGO, Calif., August 29, 2016 — Agena Bioscience today announced the successful certification of Genelex as a Certified...